Premier Biotech Adds Scale in Point-of-Care Testing with GH Solutions Acquisition

CLEVELAND & DALLAS--(BUSINESS WIRE)--Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired GH Solutions (“GH”), a distributor of point-of-care diagnostic testing products. GH Solutions serves customers across the United States, primarily in the government and workplace end markets. This combination increases Premier’s customer base and broadens the solutions that GH can offer to its existing network. GH’s dedication to superior customer service and its long-tenured customer portfolio made it a natural fit with Premier.

“Working with Premier Biotech is an exciting next step for GH. We are looking forward to the partnership opportunity and bringing Premier Biotech’s full solution to our customer base. Premier’s oral fluid, laboratory and technology portfolio is unmatched in the industry and is expected to be game changing to our customers,” said David Link, CEO of GH Solutions.

“The acquisition marks another pivotal step in our growth journey and bolsters our leadership position across the drug and alcohol testing industry,” said Premier CEO Matt Michalik. “GH adds meaningful, long-term customers to our Government and Workplace businesses with significant cross-sell potential. We view the partnership as another key milestone in our ongoing efforts to differentiate ourselves in the market.”

Premier Biotech has completed five acquisitions since partnering with ACP in November of 2022. The Company will continue to pursue additional acquisitions and collaboration opportunities to further accelerate its growth. The ACP team of Rob Langley, Ervin Cash, Matt Bowen and Sarah Mahosky worked alongside Premier Management on the transaction.

About Premier Biotech

Premier Biotech delivers rapid and innovative diagnostic solutions that promote health, safety and compliance. The Company is a leading provider of proprietary oral fluid (OralTox® and OT-Scan®) and other products, services and technology solutions designed to simplify and provide a seamless end-to-end experience for customers. Premier differentiates itself through its fully integrated service offering that is augmented with high levels of service, technical expertise and configurability. The Company’s integrated offering is utilized in workplace (pre-employment and post-employment), government (child and family services, probation, parole, corrections, law enforcement and DOT) and healthcare settings. For more information, visit innovation.premierbiotech.com.

About Align Capital Partners

Align Capital Partners is a growth-oriented private equity firm that partners with business owners and management teams to help create shared success. ACP manages $2.1 billion in committed capital with investment teams in Cleveland and Dallas. ACP brings experience and resources to help lower-middle market companies accelerate their growth, to the benefit of management, employees, and the firm’s investors. ACP makes control investments in differentiated companies within the business services, technology, specialty manufacturing and distribution sectors. For more information, visit aligncp.com.